US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CNS Pharmaceuticals, Inc.

1.04

+0.03002.97%

Post-market: 1.01-0.0288-2.77%19:47 EDT

Volume:202.43K

Turnover:211.00K

Market Cap:5.68M

PE:-0.03

High:1.07

Open:1.01

Low:1.00

Close:1.01

Loading ...

Overview Company News Filings

CNS Pharmaceuticals Announces Promising Results for TPI 287 in Glioblastoma Treatment at 2025 Brain Tumor Biotech Summit

CNS Pharmaceuticals Q4 EPS $(1.58) Beats $(6.00) Estimate

CNS Pharmaceuticals Reports Q1 2025 Financials: Net Loss Increases to $4.3 Million, R&D Expenses Rise

CNS Pharmaceuticals Q1 Net Income USD -4.3 Million

THOMSON REUTERS

CNS Pharmaceuticals Inc. Raises $5 Million Through Public Offering of Common Stock and Warrants

Sector Update: Health Care Stocks Decline Tuesday Afternoon

MT Newswires Live

Wall Street Set to Open Mixed Tuesday as Inflation Reading Lower Than Expected

MT Newswires Live

Sector Update: Health Care Stocks Mixed Premarket Tuesday

MT Newswires Live

CNS Pharmaceuticals Acquires Orphan Drug Designation for TPI 287 in Glioblastoma

MT Newswires Live

CNS Pharmaceuticals reports FY24 EPS ($38.87) vs. ($12,509.11) last year

CNS Pharmaceuticals Reports Full Year 2024 Financial Results

ACCESS Newswire

CNS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

CNS Pharmaceuticals Inc expected to post a loss of $9.66 a share - Earnings Preview

CNS Pharmaceuticals announces primary analysis of berubicin in GBM

CNS Pharmaceuticals Cut to Hold From Buy by Maxim Group

CNS Pharma Shares Sink After Berubicin Trial for Brain Cancer Misses Survival Endpoint

CNS Pharmaceuticals - Berubicin Showed Clinically Relevant Outcomes Comparable to Lomustine Across Multiple Endpoints

THOMSON REUTERS

CNS Pharmaceuticals Inc: Berubicin Did Not Show a Statistically Significant Difference in Overall Survival, the Primary Endpoint

THOMSON REUTERS

CNS Pharmaceuticals Inc -Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme

THOMSON REUTERS

CNS Pharmaceuticals-Continues Development of Novel Taxane, TPI 287, With Published Clinical Efficacy Data in Glioblastoma Multiforme

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CNSP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNSP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSP\",,,,,undefined,":{"symbol":"CNSP","market":"US","secType":"STK","nameCN":"CNS Pharmaceuticals, Inc.","latestPrice":1.04,"timestamp":1749240000000,"preClose":1.01,"halted":0,"volume":202433,"hourTrading":{"tag":"盘后","latestPrice":1.0112,"preClose":1.04,"latestTime":"19:47 EDT","volume":4440,"amount":4561.9062,"timestamp":1749253657188},"delay":0,"floatShares":5440100,"shares":5461951,"eps":-38.870243,"marketStatus":"Market Closed","change":0.03,"latestTime":"06-06 16:00:00 EDT","open":1.01,"high":1.07,"low":1,"amount":210996.44222579998,"amplitude":0.069307,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-38.870243,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":1.01,"preHourTrading":{"tag":"盘前","latestPrice":1.0397,"preClose":1.01,"latestTime":"09:27 EDT","volume":5424,"amount":5559.2647968,"timestamp":1749216476477},"postHourTrading":{"tag":"盘后","latestPrice":1.0112,"preClose":1.04,"latestTime":"19:47 EDT","volume":4440,"amount":4561.9062,"timestamp":1749253657188},"volumeRatio":0.8409165495243822},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNSP\",,,,,undefined,":{"symbol":"CNSP","floatShares":5440100,"roa":"-127.31%","roe":"-477.53%","lyrEps":-38.870244,"volumeRatio":0.8409165495243822,"shares":5461951,"dividePrice":0,"high":1.07,"amplitude":0.069307,"preClose":1.01,"low":1,"week52Low":0.771525,"pbRate":"0.52","week52High":414,"institutionHeld":0,"latestPrice":1.04,"eps":-38.870243,"divideRate":0,"volume":202433,"delay":0,"ttmEps":-38.870243,"open":1.01,"prevYearClose":6.02,"prevWeekClose":1.03,"prevMonthClose":1.03,"prevQuarterClose":1.36,"fiveDayClose":1.03,"twentyDayClose":1.12,"sixtyDayClose":2.53},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNSP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2541203190","title":"CNS Pharmaceuticals Announces Promising Results for TPI 287 in Glioblastoma Treatment at 2025 Brain Tumor Biotech Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2541203190","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541203190?lang=en_us&edition=fundamental","pubTime":"2025-06-05 20:05","pubTimestamp":1749125121,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals Inc. has announced promising scientific research results concerning their lead program, TPI 287, at the Brain Tumor Biotech Summit. TPI 287, an abeotaxane, is in development for treating glioblastoma multiforme  and has been granted Orphan Drug Designation by the FDA for treating gliomas, pediatric neuroblastoma, and progressive supranuclear palsy. Unlike other taxanes that struggle to penetrate the blood-brain barrier , TPI 287 has shown potential in crossing the BBB to treat central nervous system tumors. In a Phase 1 trial, when used in combination with bevacizumab, TPI 287 demonstrated efficacy with 3 Complete Responses and 9 Partial Responses among 23 evaluable glioblastoma patients. These findings highlight the drug candidate's promise as a novel treatment option for brain tumors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-genera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL1JrRb0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2535394960","title":"CNS Pharmaceuticals Q4 EPS $(1.58) Beats $(6.00) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535394960","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535394960?lang=en_us&edition=fundamental","pubTime":"2025-05-16 20:19","pubTimestamp":1747397984,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(6.00) by 73.67 percent. This is a 99.85 percent increase over losses of $(1.02 thousand) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45465785/cns-pharmaceuticals-q4-eps-1-58-beats-6-00-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSP","CNS"],"gpt_icon":0},{"id":"2535739178","title":"CNS Pharmaceuticals Reports Q1 2025 Financials: Net Loss Increases to $4.3 Million, R&D Expenses Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2535739178","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535739178?lang=en_us&edition=fundamental","pubTime":"2025-05-16 20:05","pubTimestamp":1747397159,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals Inc. has reported its financial results for the first quarter of 2025, ending March 31. The company recorded a net loss of approximately $4.3 million, an increase from the net loss of about $3.5 million during the same period in 2024. This change is largely attributable to the costs associated with data clean-up, preparation, and analysis for the topline primary data release on the Berubicin trial. Research and development expenses rose to $3.2 million from approximately $2.5 million in the previous year, primarily due to these same costs. Meanwhile, general and administrative expenses slightly decreased to approximately $1.09 million compared to $1.11 million for the comparable period in 2024. As of March 31, 2025, CNS Pharmaceuticals had cash reserves of approximately $13.1 million. Following the end of the quarter, the company completed a public offering that yielded gross proceeds of approximately $5 million. The company expects these funds to support operations","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nNDL4YVLV5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2535391277","title":"CNS Pharmaceuticals Q1 Net Income USD -4.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535391277","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535391277?lang=en_us&edition=fundamental","pubTime":"2025-05-16 20:05","pubTimestamp":1747397147,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nPLX0132B9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2535814752","title":"CNS Pharmaceuticals Inc. Raises $5 Million Through Public Offering of Common Stock and Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2535814752","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535814752?lang=en_us&edition=fundamental","pubTime":"2025-05-15 18:04","pubTimestamp":1747303456,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals Inc., a Nevada-based corporation, has announced the entry into a placement agency agreement with A.G.P./Alliance Global Partners for a public offering. The offering includes 325,000 shares of the company's common stock and pre-funded warrants to purchase 3,627,570 shares of common stock, as well as Series F Warrants for an aggregate of 3,952,570 shares. The combined purchase price for each common stock share and accompanying warrant was set at $1.265, while the pre-funded warrant and accompanying warrant were priced at $1.264. The offering was made under a Registration Statement filed with the Securities and Exchange Commission, and the company has entered into a Securities Purchase Agreement with an institutional investor participating in the offering.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250515:nNDLb7h78X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2535882090","title":"Sector Update: Health Care Stocks Decline Tuesday Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2535882090","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535882090?lang=en_us&edition=fundamental","pubTime":"2025-05-14 02:05","pubTimestamp":1747159552,"startTime":"0","endTime":"0","summary":"Health care stocks were lower Tuesday afternoon, with the NYSE Health Care Index falling 2.6% and the Health Care Select Sector SPDR Fund  dropping 2.3%.The iShares Biotechnology ETF  shed 1.5%.In corporate news, UnitedHealth  suspended its full-year outlook amid higher-than-expected medical costs, while Andrew Witty stepped down as chief executive due to \"personal reasons.\" UnitedHealth shares fell more than 16%.Alumis  shares fell past 8%. Shareholders of Alumis andAcelyrin  separately approved their merger deal at  special meetings. Acelyrin shares also fell over 9%.CNS Pharmaceuticals  shares jumped 35% after the company said it has acquired from Cortice Biosciences an orphan drug designation for late-stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4534","LU2028103732.USD","LU0320765059.SGD","IE00B19Z3B42.SGD","IE00B4JS1V06.HKD","SLRN","CNSP","IE00B1XK9C88.USD","LU0029864427.USD","LU1037948541.HKD","LU1778281490.HKD","LU0689472784.USD","IE0004445239.USD","BK4581","LU0109391861.USD","BK4154","IE00BZ1G4Q59.USD","LU2279689827.SGD","IE00BJT1NW94.SGD","LU1854103824.USD","IBB","LU0211328371.USD","LU0708995401.HKD","ALMS","LU1914381329.SGD","LU0234572021.USD","LU1003077747.HKD","IE00BKVL7J92.USD","LU0820561909.HKD","LU0738911758.USD","LU0058720904.USD","LU1069347547.HKD","BK4533","LU0456855351.SGD","LU0528227936.USD","LU1670628061.USD","LU0097036916.USD","LU1720051108.HKD","UNH","IE00B19Z9Z06.USD","LU1153585028.USD","LU0251132253.USD","LU1261432733.SGD","LU2491050071.SGD","IE00BWXC8680.SGD","LU0079474960.USD","LU0289739699.SGD","XLV","IE00B775H168.HKD","IE00BFSS8Q28.SGD"],"gpt_icon":1},{"id":"2535776737","title":"Wall Street Set to Open Mixed Tuesday as Inflation Reading Lower Than Expected","url":"https://stock-news.laohu8.com/highlight/detail?id=2535776737","media":"MT Newswires Live","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535776737?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:19","pubTimestamp":1747142397,"startTime":"0","endTime":"0","summary":"US stocks look set to open mixed Tuesday as inflation data released earlier in the morning came in lower than expected.Dow Jones Industrial Average futures were down 0.4%, S&P 500 futures were up marg","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2f77a1113b3adf8876844b719874cd9c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AXDX","BK4091","LU0683600562.USD","BK4170","BK4088","BK4161","LU0006061336.USD","LU1668664300.SGD","BK4123","BK4588","LU1791807156.HKD","XHG","APO","BK4551","BK4020","BK4585","LU1323610961.USD","IE00B775SV38.USD","BK4082","LICN.AU","GIBO","DDD","IE0002270589.USD","IE00B19Z3B42.SGD","LSEA","BK4546","BK4007","LICN","MWYN","BK4173","LU0787776722.HKD","BK4233","IE00B3S45H60.SGD","AXDXQ","SANG","LU0106831901.USD","CNSP","IE00B19Z3581.USD","LOBO","BK7145","BK4104","BK4184","BK4135"],"gpt_icon":0},{"id":"2535764757","title":"Sector Update: Health Care Stocks Mixed Premarket Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2535764757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535764757?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:16","pubTimestamp":1747142217,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed premarket Tuesday with the Health Care Select Sector SPDR Fund  down 1.2% and the iShares Biotechnology ETF  recently up 0.3%.UnitedHealth Group  shares declined by over 9% after the company suspended its 2025 outlook and named Stephen Hemsley as chief executive, effective immediately, succeeding Andrew Witty.CNS Pharmaceuticals  shares surged by over 92% after the company said it has acquired from Cortice Biosciences orphan drug designation for late-stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.Legend Biotech  shares were up over 1% after the company reported a narrower Q1 adjusted net loss as revenue more than doubled during the period.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0965509283.SGD","LU1061106388.HKD","LU0128525929.USD","LU1732800096.USD","LEGN","IE00B19Z8X17.USD","IE00B2B36J28.USD","LU1720051017.SGD","LU2133065610.SGD","LU1989771016.USD","LU0689472784.USD","LU2552382058.USD","IE00B1BXHZ80.USD","LU0029864427.USD","LU2552382132.HKD","LU0052756011.USD","UNH","IE00BKPKM429.USD","LU0345770993.USD","LU0211327993.USD","LU0672654240.SGD","LU1670628061.USD","LU0310800379.SGD","LU1720051108.HKD","LU1914381329.SGD","XLV","LU0310799852.SGD","IE0004445239.USD","LU1267930573.SGD","LU1037948897.HKD","SG9999014880.SGD","LU1003077747.HKD","LU0787776722.HKD","IBB","SG9999014914.USD","LU1551013342.USD","IE00BJT1NW94.SGD","LU1791710400.SGD","LU2089984988.USD","LU0158827781.USD","LU1854104046.USD","IE00B775H168.HKD","LU2468319806.SGD","BK4588","IE00B894F039.SGD","CNSP","IE00BZ1G4Q59.USD","SG9999002232.USD","LU0976567544.SGD","LU1496350502.SGD"],"gpt_icon":1},{"id":"2535777899","title":"CNS Pharmaceuticals Acquires Orphan Drug Designation for TPI 287 in Glioblastoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2535777899","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535777899?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:32","pubTimestamp":1747139577,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals  said Tuesday it has acquired from Cortice Biosciences orphan drug designation for late stage abeotaxane TPI 287 as a potential treatment for glioblastoma multiforme.The company said it aims to begin enrolling patients for a phase 2 study around the end of this year. Clinical data from a phase 1 trial showed that TPI 287 has the potential to cross the blood brain barrier and treat central nervous system tumors, according to the company.TPI 287 was previously granted orphan drug designation by the US Food and Drug Administration in gliomas, pediatric neuroblastoma, and progressive supranuclear palsy, the company said.The company's shares surged past 120% in recent Tuesday premarket activity.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CNS","BK4007","CNSP","BK4135"],"gpt_icon":0},{"id":"2524494594","title":"CNS Pharmaceuticals reports FY24 EPS ($38.87) vs. ($12,509.11) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2524494594","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524494594?lang=en_us&edition=fundamental","pubTime":"2025-04-02 20:46","pubTimestamp":1743597995,"startTime":"0","endTime":"0","summary":"Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks.Make smarter investments with  weekly expert stock picks from the Smart Investor Newsletter.Moleculin, CNS, Global-e, Tenet, Summit: Trending by Analysts. Biotech Alert: Searches spiking for these stocks today. CNS Pharmaceuticals down 55% after Berubicin doesn’t show OS superiority in GBM. Morning Movers: Mobileye jumps following Volkswagen ADAS partnership","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cns-pharmaceuticals-reports-fy24-eps-124635719.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cns-pharmaceuticals-reports-fy24-eps-124635719.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CNSP","CNS"],"gpt_icon":0},{"id":"2524115923","title":"CNS Pharmaceuticals Reports Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2524115923","media":"ACCESS Newswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524115923?lang=en_us&edition=fundamental","pubTime":"2025-04-01 20:05","pubTimestamp":1743509100,"startTime":"0","endTime":"0","summary":"Company advancing plans to develop TPI 287, a novel, late stage abeotaxane that is potentially blood brain barrier permeable with published clinical efficacy data in glioblastoma multiforme  for treatment of brain malignancies. CNS Pharmaceuticals plans to engage the FDA and obtain feedback on the design of a study potentially focused on the registration of TPI 287 in recurrent GBM in 2025.The Company recently reported results from the primary analysis of Berubicin in second line treatment of glioblastoma multiforme . The trial compared Berubicin to Lomustine, a current standard of care in GBM. The analysis did not demonstrate statistically significant superiority in overall survival, the primary endpoint. However, although the trial was","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cns-pharmaceuticals-reports-full-2024-120500175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","OS","PFS","CNS","CNSP","BK4097","BK4211","BK4135","BK4195"],"gpt_icon":0},{"id":"2524168269","title":"CNS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2524168269","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524168269?lang=en_us&edition=fundamental","pubTime":"2025-04-01 16:34","pubTimestamp":1743496497,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryCNS Pharmaceuticals Inc CNSP.OQ reported a quarterly adjusted loss of $9.25 per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250401:nL5N3QF0GS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSP"],"gpt_icon":0},{"id":"2522009524","title":"CNS Pharmaceuticals Inc  expected to post a loss of $9.66 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2522009524","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522009524?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:02","pubTimestamp":1743159728,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals Inc  expected to post a loss of $9.66 a share - Earnings Preview CNS Pharmaceuticals Inc CNSP.OQ CNSP.O is expected to report resultson March 31 (estimated) for the period ending D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nL5N3QB0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNSP"],"gpt_icon":0},{"id":"2522890778","title":"CNS Pharmaceuticals announces primary analysis of berubicin in GBM","url":"https://stock-news.laohu8.com/highlight/detail?id=2522890778","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522890778?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:36","pubTimestamp":1742927809,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals (CNSP) announced the primary analysis of its clinical trial evaluating Berubicin, the first anthracycline demonstrated to exten...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-announces-primary-analysis-of-berubicin-in-gbm?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/cns-pharmaceuticals-announces-primary-analysis-of-berubicin-in-gbm?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4135","BK4007","CNSP","CNS"],"gpt_icon":0},{"id":"2522889320","title":"CNS Pharmaceuticals Cut to Hold From Buy by Maxim Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2522889320","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522889320?lang=en_us&edition=fundamental","pubTime":"2025-03-26 02:26","pubTimestamp":1742927160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNSP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 25, 2025 14:26 ET (18:26 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CNS","CNSP","BK4135"],"gpt_icon":0},{"id":"2522075290","title":"CNS Pharma Shares Sink After Berubicin Trial for Brain Cancer Misses Survival Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522075290","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522075290?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:49","pubTimestamp":1742906940,"startTime":"0","endTime":"0","summary":"CNS Pharmaceuticals said its Berubicin treatment for an aggressive and usually fatal brain cancer didn't show a statistically significant difference in overall survival during a clinical trial, leading to a selloff of its shares.The biopharmaceutical company said Tuesday that superiority in overall survival had been the primary endpoint of the trial for Berubicin, though the treatment still shows a favorable safety profile. An analysis of the trial's outcomes is still ongoing, CNS said.Shares fell 55% to $1.52 in premarket trading.The trial was comparing Berubicin to Lomustine, which is the current standard of care in recurrent or progressive Glioblastoma Multiforme.CNS said the trial data shows overall survival is comparable between the two treatments, including for patients with the most unfavorable tumor markers.\"We are awaiting long-term follow-up of patients still alive as well as those still on trial, and will evaluate our substantial clinical dataset to obtain additional insight","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4135","CNSP","CNS"],"gpt_icon":0},{"id":"2522676022","title":"CNS Pharmaceuticals - Berubicin Showed Clinically Relevant Outcomes Comparable to Lomustine Across Multiple Endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2522676022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522676022?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:03","pubTimestamp":1742904190,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q818P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2522283022","title":"CNS Pharmaceuticals Inc: Berubicin Did Not Show a Statistically Significant Difference in Overall Survival, the Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2522283022","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522283022?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:03","pubTimestamp":1742904190,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q818P:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNSP","BK4007"],"gpt_icon":0},{"id":"2522022609","title":"CNS Pharmaceuticals Inc -Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme","url":"https://stock-news.laohu8.com/highlight/detail?id=2522022609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522022609?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:03","pubTimestamp":1742904190,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q818P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","CNSP"],"gpt_icon":0},{"id":"2522022405","title":"CNS Pharmaceuticals-Continues Development of Novel Taxane, TPI 287, With Published Clinical Efficacy Data in Glioblastoma Multiforme","url":"https://stock-news.laohu8.com/highlight/detail?id=2522022405","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522022405?lang=en_us&edition=fundamental","pubTime":"2025-03-25 20:03","pubTimestamp":1742904190,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nFWN3Q818P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNSP","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":29,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNSP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-15","symbol":"CNSP","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"post","actualEps":-1.58},{"date":"2025-03-31","symbol":"CNSP","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743451200000,"name":null,"time":"Post Market","dateTimestamp":1743393600000,"actualEps":null},{"market":"US","date":"2025-02-21","symbol":"CNSP","defaultRemindTime":1740148200000,"type":"split","dateTimestamp":1740114000000,"forFactor":50,"toFactor":1,"ratio":50},{"date":"2024-11-15","symbol":"CNSP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1731661200000,"name":null,"time":"Pre-Market","dateTimestamp":1731646800000,"actualEps":null},{"date":"2024-08-15","symbol":"CNSP","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723708800000,"name":null,"time":"Pre-Market","dateTimestamp":1723694400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNSP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNSP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1742961600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CNSP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CNSP","date":"2025-06-06","current":-0.353301,"percent":0.648133,"low":-11.104142,"twenty":-4.035325,"median":-0.602101,"eighty":-0.234704,"high":-0.022531,"avg":-1.791778,"sd":2.159439,"marketCap":5516570},"quantilePoints":[{"date":"2020-06-12","current":-7.212137,"twenty":-10.182711,"median":-8.715222,"eighty":-8.058906,"marketCap":40632034},{"date":"2020-06-19","current":-6.686556,"twenty":-10.140283,"median":-8.67229,"eighty":-8.058804,"marketCap":37670995},{"date":"2020-06-26","current":-5.985782,"twenty":-9.61495,"median":-8.605065,"eighty":-7.976361,"marketCap":33722943},{"date":"2020-07-02","current":-6.04418,"twenty":-9.52608,"median":-8.56496,"eighty":-7.876805,"marketCap":34051947},{"date":"2020-07-10","current":-5.460201,"twenty":-9.485529,"median":-8.527439,"eighty":-7.766917,"marketCap":30761904},{"date":"2020-07-17","current":-5.985782,"twenty":-9.470344,"median":-8.49163,"eighty":-7.662913,"marketCap":33722943},{"date":"2020-07-24","current":-5.722991,"twenty":-9.467693,"median":-8.485592,"eighty":-7.39317,"marketCap":32242423},{"date":"2020-07-31","current":-5.431002,"twenty":-9.461807,"median":-8.471019,"eighty":-7.213438,"marketCap":30597402},{"date":"2020-08-07","current":-5.475968,"twenty":-9.393331,"median":-8.454019,"eighty":-6.996065,"marketCap":30850735},{"date":"2020-08-14","current":-3.793283,"twenty":-9.342638,"median":-8.388576,"eighty":-6.686556,"marketCap":29116883},{"date":"2020-08-21","current":-3.707559,"twenty":-9.253724,"median":-8.359132,"eighty":-6.229268,"marketCap":28458873},{"date":"2020-08-28","current":-5.079142,"twenty":-9.218887,"median":-8.307367,"eighty":-6.03834,"marketCap":38987012},{"date":"2020-09-04","current":-4.607661,"twenty":-9.210194,"median":-8.272609,"eighty":-5.985782,"marketCap":35367965},{"date":"2020-09-11","current":-4.307627,"twenty":-9.199014,"median":-8.244301,"eighty":-5.722991,"marketCap":33064934},{"date":"2020-09-18","current":-4.029024,"twenty":-9.180029,"median":-8.161858,"eighty":-5.648825,"marketCap":30926406},{"date":"2020-09-25","current":-4.013414,"twenty":-9.167378,"median":-8.103698,"eighty":-5.61478,"marketCap":30806582},{"date":"2020-10-02","current":-3.970025,"twenty":-9.15648,"median":-8.058906,"eighty":-5.501547,"marketCap":30473537},{"date":"2020-10-09","current":-4.121884,"twenty":-9.139673,"median":-8.058906,"eighty":-5.448521,"marketCap":31639192},{"date":"2020-10-16","current":-3.970025,"twenty":-9.107329,"median":-8.058906,"eighty":-5.056372,"marketCap":30473537},{"date":"2020-10-23","current":-4.078496,"twenty":-9.089732,"median":-8.058855,"eighty":-4.654809,"marketCap":31306148},{"date":"2020-10-30","current":-3.648084,"twenty":-9.076826,"median":-8.058804,"eighty":-4.436213,"marketCap":28002350},{"date":"2020-11-06","current":-4.685931,"twenty":-9.0627,"median":-8.034053,"eighty":-4.359061,"marketCap":35968765},{"date":"2020-11-13","current":-3.931118,"twenty":-9.056796,"median":-7.95575,"eighty":-4.28191,"marketCap":35302677},{"date":"2020-11-20","current":-4.172177,"twenty":-9.026355,"median":-7.866443,"eighty":-4.1919,"marketCap":37467464},{"date":"2020-11-27","current":-4.450323,"twenty":-9.006899,"median":-7.818395,"eighty":-4.200472,"marketCap":39965295},{"date":"2020-12-04","current":-4.190721,"twenty":-9.006899,"median":-7.766917,"eighty":-4.174923,"marketCap":37633986},{"date":"2020-12-11","current":-4.450323,"twenty":-9.002031,"median":-7.677402,"eighty":-4.179041,"marketCap":39965295},{"date":"2020-12-18","current":-5.35893,"twenty":-8.991352,"median":-7.562524,"eighty":-4.179041,"marketCap":48124876},{"date":"2020-12-24","current":-4.579899,"twenty":-8.982166,"median":-7.40193,"eighty":-4.181377,"marketCap":41128934},{"date":"2020-12-31","current":-4.579899,"twenty":-8.965677,"median":-7.254985,"eighty":-4.190721,"marketCap":41128934},{"date":"2021-01-08","current":-4.657089,"twenty":-8.944265,"median":-7.21295,"eighty":-4.200472,"marketCap":41822118},{"date":"2021-01-15","current":-4.940116,"twenty":-8.941693,"median":-7.066142,"eighty":-4.200472,"marketCap":44363794},{"date":"2021-01-22","current":-5.248873,"twenty":-8.927903,"median":-6.949347,"eighty":-4.20685,"marketCap":47136531},{"date":"2021-01-29","current":-4.569168,"twenty":-8.921414,"median":-6.744954,"eighty":-4.228908,"marketCap":41032566},{"date":"2021-02-05","current":-8.925817,"twenty":-8.924728,"median":-6.686556,"eighty":-4.241472,"marketCap":80156642},{"date":"2021-02-12","current":-9.202382,"twenty":-8.969799,"median":-6.905549,"eighty":-4.245747,"marketCap":87034942},{"date":"2021-02-19","current":-8.239342,"twenty":-8.95283,"median":-7.036943,"eighty":-4.257476,"marketCap":77926633},{"date":"2021-02-26","current":-7.035542,"twenty":-8.942722,"median":-7.066142,"eighty":-4.290533,"marketCap":66541248},{"date":"2021-03-05","current":-6.286511,"twenty":-8.932167,"median":-7.077593,"eighty":-4.348741,"marketCap":59457009},{"date":"2021-03-12","current":-7.142546,"twenty":-8.925,"median":-7.066142,"eighty":-4.379789,"marketCap":67553283},{"date":"2021-03-19","current":-7.2228,"twenty":-8.922175,"median":-7.115795,"eighty":-4.388896,"marketCap":68312309},{"date":"2021-03-26","current":-6.313262,"twenty":-8.914185,"median":-7.089044,"eighty":-4.394157,"marketCap":59710017},{"date":"2021-04-01","current":-6.313262,"twenty":-8.907461,"median":-7.066142,"eighty":-4.398402,"marketCap":59710017},{"date":"2021-04-09","current":-5.965498,"twenty":-8.895601,"median":-7.021643,"eighty":-4.408292,"marketCap":56420906},{"date":"2021-04-16","current":-5.564231,"twenty":-8.876918,"median":-6.86175,"eighty":-4.423354,"marketCap":52625778},{"date":"2021-04-23","current":-5.483978,"twenty":-8.86666,"median":-6.754656,"eighty":-4.436213,"marketCap":51866752},{"date":"2021-04-30","current":-5.350222,"twenty":-8.86434,"median":-6.686556,"eighty":-4.441857,"marketCap":50601710},{"date":"2021-05-07","current":-4.922204,"twenty":-8.83789,"median":-6.521764,"eighty":-4.450323,"marketCap":46553573},{"date":"2021-05-14","current":-4.088275,"twenty":-8.792323,"median":-6.447018,"eighty":-4.441857,"marketCap":45392708},{"date":"2021-05-21","current":-4.270991,"twenty":-8.7716,"median":-6.313262,"eighty":-4.398402,"marketCap":47421433},{"date":"2021-05-28","current":-4.225312,"twenty":-8.759004,"median":-6.292371,"eighty":-4.340462,"marketCap":46914251},{"date":"2021-06-04","current":-4.682103,"twenty":-8.75657,"median":-6.248572,"eighty":-4.321238,"marketCap":51986063},{"date":"2021-06-11","current":-4.590745,"twenty":-8.749711,"median":-6.127315,"eighty":-4.346838,"marketCap":50971701},{"date":"2021-06-18","current":-4.659263,"twenty":-8.74176,"median":-6.04418,"eighty":-4.377364,"marketCap":51732472},{"date":"2021-06-25","current":-4.727782,"twenty":-8.717723,"median":-6.016991,"eighty":-4.384441,"marketCap":52493244},{"date":"2021-07-02","current":-4.156794,"twenty":-8.711724,"median":-5.985782,"eighty":-4.377364,"marketCap":46153480},{"date":"2021-07-09","current":-4.225312,"twenty":-8.697732,"median":-5.985782,"eighty":-4.31667,"marketCap":46914251},{"date":"2021-07-16","current":-4.156794,"twenty":-8.693756,"median":-5.911995,"eighty":-4.270991,"marketCap":46153480},{"date":"2021-07-23","current":-4.065436,"twenty":-8.66736,"median":-5.722991,"eighty":-4.24635,"marketCap":45139118},{"date":"2021-07-30","current":-3.928398,"twenty":-8.650824,"median":-5.695889,"eighty":-4.225312,"marketCap":43617574},{"date":"2021-08-06","current":-3.814201,"twenty":-8.607892,"median":-5.657779,"eighty":-4.202473,"marketCap":42349622},{"date":"2021-08-13","current":-3.685543,"twenty":-8.605065,"median":-5.635395,"eighty":-4.200472,"marketCap":45859381},{"date":"2021-08-20","current":-3.310368,"twenty":-8.584026,"median":-5.620503,"eighty":-4.179041,"marketCap":41191061},{"date":"2021-08-27","current":-3.575197,"twenty":-8.56496,"median":-5.570614,"eighty":-4.156794,"marketCap":44486345},{"date":"2021-09-03","current":-3.685543,"twenty":-8.532851,"median":-5.547798,"eighty":-4.121884,"marketCap":45859381},{"date":"2021-09-10","current":-3.376575,"twenty":-8.532851,"median":-5.537212,"eighty":-4.111115,"marketCap":42014881},{"date":"2021-09-17","current":-3.420714,"twenty":-8.524193,"median":-5.514664,"eighty":-4.111115,"marketCap":42564096},{"date":"2021-09-24","current":-3.288299,"twenty":-8.514198,"median":-5.483978,"eighty":-4.079269,"marketCap":40916453},{"date":"2021-10-01","current":-3.26623,"twenty":-8.495752,"median":-5.478205,"eighty":-4.064533,"marketCap":40641846},{"date":"2021-10-08","current":-3.310368,"twenty":-8.4868,"median":-5.460201,"eighty":-4.034065,"marketCap":41191061},{"date":"2021-10-15","current":-3.244161,"twenty":-8.485592,"median":-5.430739,"eighty":-4.013414,"marketCap":40367239},{"date":"2021-10-22","current":-3.111746,"twenty":-8.485592,"median":-5.430475,"eighty":-3.99323,"marketCap":38719597},{"date":"2021-10-29","current":-3.045538,"twenty":-8.480394,"median":-5.375806,"eighty":-3.970025,"marketCap":37895775},{"date":"2021-11-05","current":-2.780709,"twenty":-8.472634,"median":-5.350222,"eighty":-3.951238,"marketCap":34600490},{"date":"2021-11-12","current":-2.410639,"twenty":-8.460436,"median":-5.296139,"eighty":-3.947325,"marketCap":34342752},{"date":"2021-11-19","current":-2.23425,"twenty":-8.457661,"median":-5.197414,"eighty":-3.928398,"marketCap":31829869},{"date":"2021-11-26","current":-2.253849,"twenty":-8.453296,"median":-5.079142,"eighty":-3.92473,"marketCap":32109078},{"date":"2021-12-03","current":-1.950069,"twenty":-8.450408,"median":-5.049497,"eighty":-3.900579,"marketCap":27781332},{"date":"2021-12-10","current":-1.999066,"twenty":-8.413309,"median":-4.980019,"eighty":-3.872026,"marketCap":28479356},{"date":"2021-12-17","current":-1.763882,"twenty":-8.386969,"median":-4.937368,"eighty":-3.857576,"marketCap":25128844},{"date":"2021-12-23","current":-1.699794,"twenty":-8.378724,"median":-4.922204,"eighty":-3.836503,"marketCap":24215829},{"date":"2021-12-31","current":-1.376612,"twenty":-8.360899,"median":-4.862927,"eighty":-3.803564,"marketCap":19611666},{"date":"2022-01-07","current":-1.45971,"twenty":-8.338858,"median":-4.8152,"eighty":-3.779656,"marketCap":20795514},{"date":"2022-01-14","current":-1.499104,"twenty":-8.315965,"median":-4.798182,"eighty":-3.707731,"marketCap":21356724},{"date":"2022-01-21","current":-1.304293,"twenty":-8.307367,"median":-4.788449,"eighty":-3.685543,"marketCap":18581383},{"date":"2022-01-28","current":-1.143387,"twenty":-8.30205,"median":-4.777198,"eighty":-3.645307,"marketCap":16289074},{"date":"2022-02-04","current":-0.862342,"twenty":-8.277513,"median":-4.760008,"eighty":-3.579611,"marketCap":12285212},{"date":"2022-02-11","current":-0.695753,"twenty":-8.260408,"median":-4.727782,"eighty":-3.491335,"marketCap":9911932},{"date":"2022-02-18","current":-0.660868,"twenty":-8.244301,"median":-4.704942,"eighty":-3.420714,"marketCap":9414940},{"date":"2022-02-25","current":-0.666551,"twenty":-8.244301,"median":-4.682818,"eighty":-3.420714,"marketCap":9495910},{"date":"2022-03-04","current":-0.894105,"twenty":-8.239342,"median":-4.677028,"eighty":-3.376575,"marketCap":12550175},{"date":"2022-03-11","current":-0.960557,"twenty":-8.223896,"median":-4.657089,"eighty":-3.332437,"marketCap":13482932},{"date":"2022-03-18","current":-0.941163,"twenty":-8.212591,"median":-4.630225,"eighty":-3.288299,"marketCap":13210710},{"date":"2022-03-25","current":-0.955138,"twenty":-8.18584,"median":-4.607661,"eighty":-3.26623,"marketCap":13406870},{"date":"2022-04-01","current":-0.969683,"twenty":-8.161858,"median":-4.590745,"eighty":-3.200022,"marketCap":13611036},{"date":"2022-04-08","current":-1.026438,"twenty":-8.141247,"median":-4.590745,"eighty":-3.155884,"marketCap":14407681},{"date":"2022-04-14","current":-1.112569,"twenty":-8.119587,"median":-4.579899,"eighty":-3.133815,"marketCap":15616661},{"date":"2022-04-22","current":-0.955423,"twenty":-8.097414,"median":-4.567905,"eighty":-3.063194,"marketCap":13410874},{"date":"2022-04-29","current":-0.96455,"twenty":-8.068573,"median":-4.55417,"eighty":-2.996986,"marketCap":13538977},{"date":"2022-05-06","current":-0.896672,"twenty":-8.059607,"median":-4.544052,"eighty":-2.930779,"marketCap":12586204},{"date":"2022-05-13","current":-0.878394,"twenty":-8.058906,"median":-4.522226,"eighty":-2.714502,"marketCap":11601405},{"date":"2022-05-20","current":-0.836566,"twenty":-8.058906,"median":-4.491466,"eighty":-2.38712,"marketCap":11048958},{"date":"2022-05-27","current":-0.893853,"twenty":-8.058906,"median":-4.453708,"eighty":-2.23033,"marketCap":11805571},{"date":"2022-06-03","current":-0.982056,"twenty":-8.058906,"median":-4.450323,"eighty":-2.187213,"marketCap":12970516},{"date":"2022-06-10","current":-0.86915,"twenty":-8.058906,"median":-4.436213,"eighty":-2.069621,"marketCap":11479307},{"date":"2022-06-17","current":-0.84869,"twenty":-8.058906,"median":-4.414782,"eighty":-1.955949,"marketCap":11209088},{"date":"2022-06-24","current":-0.802618,"twenty":-8.058906,"median":-4.394694,"eighty":-1.894409,"marketCap":10600594},{"date":"2022-07-01","current":-0.803225,"twenty":-8.058865,"median":-4.379183,"eighty":-1.786224,"marketCap":10608600},{"date":"2022-07-08","current":-0.861121,"twenty":-8.058804,"median":-4.33951,"eighty":-1.744165,"marketCap":11373261},{"date":"2022-07-15","current":-0.81838,"twenty":-8.058804,"median":-4.307627,"eighty":-1.52372,"marketCap":10808764},{"date":"2022-07-22","current":-0.680468,"twenty":-8.056743,"median":-4.267942,"eighty":-1.485463,"marketCap":8987286},{"date":"2022-07-29","current":-0.665919,"twenty":-8.046479,"median":-4.248152,"eighty":-1.450616,"marketCap":8795130},{"date":"2022-08-05","current":-0.68562,"twenty":-8.036661,"median":-4.238679,"eighty":-1.405148,"marketCap":9055341},{"date":"2022-08-12","current":-0.789542,"twenty":-8.023482,"median":-4.225312,"eighty":-1.26243,"marketCap":10232295},{"date":"2022-08-19","current":-0.762977,"twenty":-7.994138,"median":-4.205459,"eighty":-1.210197,"marketCap":9888017},{"date":"2022-08-26","current":-0.795102,"twenty":-7.972239,"median":-4.202473,"eighty":-1.136599,"marketCap":10304354},{"date":"2022-09-02","current":-0.765448,"twenty":-7.951628,"median":-4.201473,"eighty":-1.104811,"marketCap":9920043},{"date":"2022-09-09","current":-0.723438,"twenty":-7.93514,"median":-4.195597,"eighty":-1.026438,"marketCap":9375602},{"date":"2022-09-16","current":-0.735176,"twenty":-7.891578,"median":-4.179041,"eighty":-0.988792,"marketCap":9527725},{"date":"2022-09-23","current":-0.592465,"twenty":-7.883713,"median":-4.156794,"eighty":-0.977954,"marketCap":7678224},{"date":"2022-09-30","current":-0.552926,"twenty":-7.849173,"median":-4.156794,"eighty":-0.969683,"marketCap":7165809},{"date":"2022-10-07","current":-0.595245,"twenty":-7.825315,"median":-4.121884,"eighty":-0.962657,"marketCap":7714254},{"date":"2022-10-14","current":-0.632622,"twenty":-7.811475,"median":-4.116548,"eighty":-0.954777,"marketCap":8198647},{"date":"2022-10-21","current":-0.573005,"twenty":-7.766917,"median":-4.111115,"eighty":-0.9443,"marketCap":7426020},{"date":"2022-10-28","current":-0.556015,"twenty":-7.766917,"median":-4.111115,"eighty":-0.939621,"marketCap":7205842},{"date":"2022-11-04","current":-0.588449,"twenty":-7.749643,"median":-4.090796,"eighty":-0.931134,"marketCap":7626182},{"date":"2022-11-11","current":-0.60216,"twenty":-7.70432,"median":-4.078496,"eighty":-0.916921,"marketCap":7566134},{"date":"2022-11-18","current":-0.637206,"twenty":-7.68781,"median":-4.068661,"eighty":-0.904087,"marketCap":8006492},{"date":"2022-11-25","current":-0.669066,"twenty":-7.671157,"median":-4.053437,"eighty":-0.896159,"marketCap":8406816},{"date":"2022-12-02","current":-0.293114,"twenty":-7.65067,"median":-4.035325,"eighty":-0.876802,"marketCap":3682982},{"date":"2022-12-09","current":-0.296301,"twenty":-7.585769,"median":-4.021358,"eighty":-0.866212,"marketCap":3723015},{"date":"2022-12-16","current":-0.311275,"twenty":-7.564132,"median":-4.013414,"eighty":-0.85839,"marketCap":3911167},{"date":"2022-12-23","current":-0.23258,"twenty":-7.504754,"median":-4.003511,"eighty":-0.84869,"marketCap":2922366},{"date":"2022-12-30","current":-0.254882,"twenty":-7.45106,"median":-3.99172,"eighty":-0.84481,"marketCap":3202593},{"date":"2023-01-06","current":-0.307983,"twenty":-7.415708,"median":-3.978386,"eighty":-0.834566,"marketCap":3869800},{"date":"2023-01-13","current":-0.254882,"twenty":-7.384411,"median":-3.970025,"eighty":-0.821191,"marketCap":3202593},{"date":"2023-01-20","current":-0.234704,"twenty":-7.357817,"median":-3.951238,"eighty":-0.816067,"marketCap":2949054},{"date":"2023-01-27","current":-0.238952,"twenty":-7.351205,"median":-3.948331,"eighty":-0.808237,"marketCap":3002431},{"date":"2023-02-03","current":-0.260192,"twenty":-7.324454,"median":-3.9433,"eighty":-0.803286,"marketCap":3269314},{"date":"2023-02-10","current":-0.202844,"twenty":-7.293439,"median":-3.928398,"eighty":-0.797434,"marketCap":2548730},{"date":"2023-02-17","current":-0.177355,"twenty":-7.252255,"median":-3.928398,"eighty":-0.789914,"marketCap":2228471},{"date":"2023-02-24","current":-0.175231,"twenty":-7.241336,"median":-3.921869,"eighty":-0.786554,"marketCap":2201783},{"date":"2023-03-03","current":-0.182666,"twenty":-7.2228,"median":-3.905251,"eighty":-0.782877,"marketCap":2295192},{"date":"2023-03-10","current":-0.132751,"twenty":-7.2228,"median":-3.883249,"eighty":-0.764349,"marketCap":1668017},{"date":"2023-03-17","current":-0.118945,"twenty":-7.2228,"median":-3.870281,"eighty":-0.761396,"marketCap":1494543},{"date":"2023-03-24","current":-0.121069,"twenty":-7.213763,"median":-3.85988,"eighty":-0.756799,"marketCap":1521231},{"date":"2023-03-31","current":-0.106201,"twenty":-7.212137,"median":-3.857261,"eighty":-0.742898,"marketCap":1334414},{"date":"2023-04-06","current":-0.09197,"twenty":-7.156464,"median":-3.836593,"eighty":-0.741354,"marketCap":1155602},{"date":"2023-04-14","current":-0.099844,"twenty":-7.099744,"median":-3.814201,"eighty":-0.72838,"marketCap":1525032},{"date":"2023-04-21","current":-0.381886,"twenty":-7.089044,"median":-3.794878,"eighty":-0.708654,"marketCap":5832971},{"date":"2023-04-28","current":-0.250704,"twenty":-7.070722,"median":-3.791361,"eighty":-0.69694,"marketCap":3829279},{"date":"2023-05-05","current":-0.237585,"twenty":-7.066142,"median":-3.737297,"eighty":-0.689746,"marketCap":3628909},{"date":"2023-05-11","current":-0.231755,"twenty":-7.063833,"median":-3.707774,"eighty":-0.675907,"marketCap":3539856},{"date":"2023-05-17","current":-0.18074,"twenty":-7.056943,"median":-3.688002,"eighty":-0.668824,"marketCap":2760643},{"date":"2023-05-26","current":-0.336756,"twenty":-7.040892,"median":-3.685543,"eighty":-0.666773,"marketCap":5743143},{"date":"2023-06-02","current":-0.439739,"twenty":-7.029983,"median":-3.674508,"eighty":-0.666081,"marketCap":7499443},{"date":"2023-06-06","current":-0.575791,"twenty":-7.018864,"median":-3.663474,"eighty":-0.665798,"marketCap":9819713},{"date":"2023-06-16","current":-0.524771,"twenty":-6.996065,"median":-3.648084,"eighty":-0.662279,"marketCap":8949612},{"date":"2023-06-23","current":-0.585509,"twenty":-6.961027,"median":-3.643009,"eighty":-0.658608,"marketCap":9985446},{"date":"2023-06-30","current":-0.524771,"twenty":-6.949347,"median":-3.641405,"eighty":-0.655007,"marketCap":8949612},{"date":"2023-07-06","current":-0.544207,"twenty":-6.931828,"median":-3.619336,"eighty":-0.653424,"marketCap":9281079},{"date":"2023-07-14","current":-0.546637,"twenty":-6.896789,"median":-3.597266,"eighty":-0.650323,"marketCap":9322512},{"date":"2023-07-21","current":-0.519912,"twenty":-6.85007,"median":-3.575197,"eighty":-0.648351,"marketCap":8866745},{"date":"2023-07-28","current":-0.500477,"twenty":-6.796288,"median":-3.520024,"eighty":-0.633539,"marketCap":8535278},{"date":"2023-08-04","current":-0.53206,"twenty":-6.762681,"median":-3.486921,"eighty":-0.623447,"marketCap":9073912},{"date":"2023-08-11","current":-0.490758,"twenty":-6.730335,"median":-3.420714,"eighty":-0.617301,"marketCap":8369544},{"date":"2023-08-18","current":-0.45116,"twenty":-6.686556,"median":-3.420714,"eighty":-0.60226,"marketCap":7899628},{"date":"2023-08-25","current":-0.419963,"twenty":-6.665399,"median":-3.387609,"eighty":-0.593021,"marketCap":7353377},{"date":"2023-09-01","current":-0.410364,"twenty":-6.57857,"median":-3.376575,"eighty":-0.587708,"marketCap":7185300},{"date":"2023-09-08","current":-0.369567,"twenty":-6.56976,"median":-3.354506,"eighty":-0.587214,"marketCap":6470972},{"date":"2023-09-15","current":-0.347969,"twenty":-6.473769,"median":-3.321403,"eighty":-0.575791,"marketCap":6092798},{"date":"2023-09-22","current":-0.292774,"twenty":-6.473769,"median":-3.288299,"eighty":-0.570688,"marketCap":5126354},{"date":"2023-09-29","current":-0.263977,"twenty":-6.447018,"median":-3.288299,"eighty":-0.561214,"marketCap":4622123},{"date":"2023-10-06","current":-0.261577,"twenty":-6.393515,"median":-3.26623,"eighty":-0.556015,"marketCap":4580103},{"date":"2023-10-13","current":-0.275976,"twenty":-6.313262,"median":-3.233126,"eighty":-0.546637,"marketCap":4832219},{"date":"2023-10-20","current":-0.475158,"twenty":-6.313262,"median":-3.177953,"eighty":-0.537636,"marketCap":8319821},{"date":"2023-10-27","current":-0.475158,"twenty":-6.313262,"median":-3.177953,"eighty":-0.53219,"marketCap":8319821},{"date":"2023-10-31","current":-0.482357,"twenty":-6.313262,"median":-3.177953,"eighty":-0.52963,"marketCap":8445879},{"date":"2023-11-10","current":-0.350369,"twenty":-6.296549,"median":-3.144849,"eighty":-0.524771,"marketCap":6134817},{"date":"2023-11-17","current":-0.474085,"twenty":-6.287683,"median":-3.133815,"eighty":-0.524285,"marketCap":8824053},{"date":"2023-11-24","current":-0.671132,"twenty":-6.263748,"median":-3.089677,"eighty":-0.524771,"marketCap":12491663},{"date":"2023-12-01","current":-0.586535,"twenty":-6.223184,"median":-3.034504,"eighty":-0.524771,"marketCap":10917083},{"date":"2023-12-08","current":-0.592175,"twenty":-6.173736,"median":-3.0014,"eighty":-0.524771,"marketCap":11022055},{"date":"2023-12-15","current":-0.496299,"twenty":-6.122368,"median":-2.979331,"eighty":-0.524771,"marketCap":9237532},{"date":"2023-12-22","current":-0.329926,"twenty":-6.100583,"median":-2.824847,"eighty":-0.519912,"marketCap":6140859},{"date":"2023-12-29","current":-0.355305,"twenty":-6.088238,"median":-2.780709,"eighty":-0.519912,"marketCap":6613233},{"date":"2024-01-05","current":-0.324286,"twenty":-6.055195,"median":-2.714502,"eighty":-0.515841,"marketCap":6035887},{"date":"2024-01-12","current":-0.284808,"twenty":-6.04418,"median":-2.474334,"eighty":-0.499641,"marketCap":5301083},{"date":"2024-01-19","current":-0.195559,"twenty":-6.029072,"median":-2.351843,"eighty":-0.492216,"marketCap":3639902},{"date":"2024-01-26","current":-0.156994,"twenty":-6.016589,"median":-2.253849,"eighty":-0.483797,"marketCap":2922103},{"date":"2024-02-02","current":-0.084307,"twenty":-5.998446,"median":-2.204853,"eighty":-0.474729,"marketCap":1569185},{"date":"2024-02-09","current":-0.084407,"twenty":-5.986438,"median":-2.175454,"eighty":-0.4526,"marketCap":1571050},{"date":"2024-02-16","current":-0.09449,"twenty":-5.985782,"median":-2.087261,"eighty":-0.435801,"marketCap":1758731},{"date":"2024-02-23","current":-0.091819,"twenty":-5.985782,"median":-2.028464,"eighty":-0.428343,"marketCap":1709014},{"date":"2024-03-01","current":-0.092821,"twenty":-5.977668,"median":-1.959869,"eighty":-0.419145,"marketCap":1727658},{"date":"2024-03-08","current":-0.146577,"twenty":-5.954797,"median":-1.929197,"eighty":-0.410364,"marketCap":2728208},{"date":"2024-03-15","current":-0.133221,"twenty":-5.917345,"median":-1.842277,"eighty":-0.401766,"marketCap":2479624},{"date":"2024-03-22","current":-0.117328,"twenty":-5.855382,"median":-1.78642,"eighty":-0.388766,"marketCap":2183809},{"date":"2024-03-28","current":-0.123539,"twenty":-5.793069,"median":-1.75418,"eighty":-0.379711,"marketCap":2299401},{"date":"2024-04-05","current":-0.158808,"twenty":-5.722991,"median":-1.699794,"eighty":-0.364925,"marketCap":2993733},{"date":"2024-04-12","current":-0.135396,"twenty":-5.71799,"median":-1.539771,"eighty":-0.356238,"marketCap":2552383},{"date":"2024-04-19","current":-0.115087,"twenty":-5.697147,"median":-1.4895,"eighty":-0.348449,"marketCap":2169526},{"date":"2024-04-26","current":-0.115087,"twenty":-5.693792,"median":-1.477349,"eighty":-0.34283,"marketCap":2169526},{"date":"2024-05-03","current":-0.121585,"twenty":-5.686589,"median":-1.45971,"eighty":-0.335804,"marketCap":2292019},{"date":"2024-05-10","current":-0.117907,"twenty":-5.653302,"median":-1.416789,"eighty":-0.324849,"marketCap":2222700},{"date":"2024-05-17","current":-0.136956,"twenty":-5.635395,"median":-1.403854,"eighty":-0.322225,"marketCap":2391796},{"date":"2024-05-24","current":-0.146045,"twenty":-5.635395,"median":-1.340453,"eighty":-0.309913,"marketCap":2550535},{"date":"2024-05-31","current":-0.147674,"twenty":-5.635395,"median":-1.244909,"eighty":-0.307983,"marketCap":2578980},{"date":"2024-06-07","current":-0.072615,"twenty":-5.63482,"median":-1.215119,"eighty":-0.296301,"marketCap":1268153},{"date":"2024-06-14","current":-0.049134,"twenty":-5.623366,"median":-1.177881,"eighty":-0.292774,"marketCap":858077},{"date":"2024-06-21","current":-0.02891,"twenty":-5.611919,"median":-1.140804,"eighty":-0.289078,"marketCap":504890},{"date":"2024-06-28","current":-0.022531,"twenty":-5.606196,"median":-1.135548,"eighty":-0.284808,"marketCap":393483},{"date":"2024-07-05","current":-0.120658,"twenty":-5.582837,"median":-1.117125,"eighty":-0.280591,"marketCap":2107180},{"date":"2024-07-12","current":-0.10413,"twenty":-5.566784,"median":-1.09289,"eighty":-0.275101,"marketCap":1818525},{"date":"2024-07-15","current":-0.202014,"twenty":-5.564231,"median":-1.082908,"eighty":-0.273576,"marketCap":3527977},{"date":"2024-08-02","current":-0.167705,"twenty":-5.564231,"median":-1.061945,"eighty":-0.273576,"marketCap":2928807},{"date":"2024-08-09","current":-0.260131,"twenty":-5.560944,"median":-1.014745,"eighty":-0.269962,"marketCap":4542928},{"date":"2024-08-16","current":-0.229148,"twenty":-5.545734,"median":-0.991073,"eighty":-0.267626,"marketCap":3660302},{"date":"2024-08-23","current":-0.348159,"twenty":-5.537426,"median":-0.982056,"eighty":-0.266776,"marketCap":5561327},{"date":"2024-08-30","current":-0.295834,"twenty":-5.534871,"median":-0.977669,"eighty":-0.267626,"marketCap":4725521},{"date":"2024-09-06","current":-0.301872,"twenty":-5.525506,"median":-0.971252,"eighty":-0.267626,"marketCap":4821960},{"date":"2024-09-13","current":-0.299859,"twenty":-5.518599,"median":-0.969683,"eighty":-0.269067,"marketCap":4789814},{"date":"2024-09-20","current":-0.304085,"twenty":-5.510729,"median":-0.963604,"eighty":-0.269652,"marketCap":4857321},{"date":"2024-09-27","current":-0.281344,"twenty":-5.483978,"median":-0.955423,"eighty":-0.26975,"marketCap":4494067},{"date":"2024-10-04","current":-0.241699,"twenty":-5.483978,"median":-0.953674,"eighty":-0.267626,"marketCap":3860783},{"date":"2024-10-11","current":-0.236265,"twenty":-5.483978,"median":-0.947152,"eighty":-0.265185,"marketCap":3773987},{"date":"2024-10-18","current":-0.241095,"twenty":-5.480441,"median":-0.941021,"eighty":-0.263659,"marketCap":3851139},{"date":"2024-10-25","current":-0.293017,"twenty":-5.475968,"median":-0.939621,"eighty":-0.263659,"marketCap":4680516},{"date":"2024-10-31","current":-0.377083,"twenty":-5.463354,"median":-0.935174,"eighty":-0.263913,"marketCap":6023354},{"date":"2024-11-08","current":-0.351013,"twenty":-5.448521,"median":-0.921531,"eighty":-0.264162,"marketCap":5606924},{"date":"2024-11-15","current":-0.369014,"twenty":-5.399307,"median":-0.910325,"eighty":-0.264162,"marketCap":5894459},{"date":"2024-11-22","current":-0.377843,"twenty":-5.347495,"median":-0.895389,"eighty":-0.264162,"marketCap":6444741},{"date":"2024-11-29","current":-0.377477,"twenty":-5.183634,"median":-0.874413,"eighty":-0.264162,"marketCap":6438511},{"date":"2024-12-06","current":-0.348155,"twenty":-5.034708,"median":-0.861732,"eighty":-0.264162,"marketCap":5938376},{"date":"2024-12-13","current":-0.357255,"twenty":-4.929654,"median":-0.855633,"eighty":-0.264162,"marketCap":6093590},{"date":"2024-12-20","current":-0.370737,"twenty":-4.828398,"median":-0.844396,"eighty":-0.264162,"marketCap":6323537},{"date":"2024-12-27","current":-0.387251,"twenty":-4.79743,"median":-0.829898,"eighty":-0.264162,"marketCap":6605222},{"date":"2025-01-03","current":-0.393992,"twenty":-4.778096,"median":-0.818802,"eighty":-0.264162,"marketCap":6720195},{"date":"2025-01-10","current":-0.390959,"twenty":-4.727782,"median":-0.810256,"eighty":-0.26407,"marketCap":6668457},{"date":"2025-01-17","current":-0.366692,"twenty":-4.682675,"median":-0.803528,"eighty":-0.26407,"marketCap":6254553},{"date":"2025-01-24","current":-0.322204,"twenty":-4.658828,"median":-0.799735,"eighty":-0.26407,"marketCap":5495729},{"date":"2025-01-31","current":-0.336359,"twenty":-4.618211,"median":-0.789542,"eighty":-0.26407,"marketCap":5737173},{"date":"2025-02-07","current":-0.309397,"twenty":-4.590745,"median":-0.784735,"eighty":-0.26407,"marketCap":5277279},{"date":"2025-02-14","current":-0.363322,"twenty":-4.567905,"median":-0.764349,"eighty":-0.26407,"marketCap":6197066},{"date":"2025-02-21","current":-0.252775,"twenty":-4.545066,"median":-0.761432,"eighty":-0.263723,"marketCap":4311502},{"date":"2025-02-28","current":-0.163124,"twenty":-4.518971,"median":-0.756799,"eighty":-0.260357,"marketCap":2782356},{"date":"2025-03-07","current":-0.18739,"twenty":-4.450323,"median":-0.742126,"eighty":-0.256777,"marketCap":3196260},{"date":"2025-03-14","current":-0.182672,"twenty":-4.414782,"median":-0.732087,"eighty":-0.25382,"marketCap":3115779},{"date":"2025-03-21","current":-0.244012,"twenty":-4.376151,"median":-0.707746,"eighty":-0.251696,"marketCap":4162037},{"date":"2025-03-28","current":-0.088977,"twenty":-4.293831,"median":-0.69595,"eighty":-0.249547,"marketCap":1517648},{"date":"2025-04-04","current":-0.087442,"twenty":-4.24635,"median":-0.685787,"eighty":-0.247788,"marketCap":1299199},{"date":"2025-04-11","current":-0.233841,"twenty":-4.225312,"median":-0.669066,"eighty":-0.245695,"marketCap":3474369},{"date":"2025-04-17","current":-0.16252,"twenty":-4.202473,"median":-0.666828,"eighty":-0.244165,"marketCap":2414686},{"date":"2025-04-25","current":-0.206098,"twenty":-4.190721,"median":-0.662338,"eighty":-0.241095,"marketCap":3062156},{"date":"2025-05-02","current":-0.210061,"twenty":-4.156794,"median":-0.65195,"eighty":-0.238952,"marketCap":3121043},{"date":"2025-05-09","current":-0.221951,"twenty":-4.121884,"median":-0.645985,"eighty":-0.237585,"marketCap":3297706},{"date":"2025-05-16","current":-0.249695,"twenty":-4.111115,"median":-0.62552,"eighty":-0.234704,"marketCap":3709920},{"date":"2025-05-23","current":-0.400524,"twenty":-4.088275,"median":-0.61858,"eighty":-0.234704,"marketCap":6253933},{"date":"2025-05-30","current":-0.374289,"twenty":-4.071886,"median":-0.614102,"eighty":-0.234704,"marketCap":5844287},{"date":"2025-06-06","current":-0.353301,"twenty":-4.035325,"median":-0.602101,"eighty":-0.234704,"marketCap":5516570}],"updateTime":1749290754496}}}